Farther Finance Advisors’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.8K | Buy |
2,477
+2,449
| +8,746% | +$27.5K | ﹤0.01% | 2463 |
|
|
2025
Q1 | $116 | Hold |
28
| – | – | ﹤0.01% | 4049 |
|
|
2024
Q4 | $158 | Sell |
28
-1
| -3% | -$6 | ﹤0.01% | 3709 |
|
|
2024
Q3 | $140 | Hold |
29
| – | – | ﹤0.01% | 3724 |
|
|
2024
Q2 | $144 | Sell |
29
-60
| -67% | -$298 | ﹤0.01% | 3547 |
|
|
2024
Q1 | $1.14K | Buy |
89
+73
| +456% | +$933 | ﹤0.01% | 2721 |
|
|
2023
Q4 | $223 | Buy |
16
+14
| +700% | +$195 | ﹤0.01% | 3206 |
|
|
2023
Q3 | $27 | Buy |
+2
| New | +$27 | ﹤0.01% | 2588 |
|